The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve ...

The Trump administration's effort to impose new requirements on Novavax's COVID-19 vaccine -- the nation's only traditional ...

There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...

Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible ...

The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...

Former government health officials fear the Trump administration is moving to slow-walk vaccine approvals, including by ...

At the peak of the COVID-19 pandemic, many vaccine skeptics turned to ivermectin, a medication proven to fight off parasitic ...

Comments over the weekend by FDA chief Martin Makary suggest the agency views Novavax’s updated COVID shot as a “new product” ...

Novavax's COVID vaccine was approved under an emergency use authorization in August 2022, and the company has pursued full ...

A new randomized study could cost Novavax tens of millions of dollars, vaccine experts say ...

Federal regulators have asked Novavax to complete an additional clinical trial on its COVID-19 vaccine after previously ...

Novavax says its closely watched COVID-19 vaccine is on track for full U.S. approval after additional discussions with the ...